A Multi-center Phase I Dose Escalation Trial to Evaluate Safety and Tolerability of Intra-arterial Temozolomide for Patients with Advanced Extremity Melanoma Using Normothermic Isolated Limb Infusion

This phase I trial reports the first use of intra arterial temozolomide via isolated limb infusion for patients with advanced extremity melanoma. There was minimal toxicity and the maximum tolerated dose was determined.

Salvato in:
Dettagli Bibliografici
Pubblicato in:Ann Surg Oncol
Autori principali: Beasley, Georgia M., Speicher, Paul, Augustine, Christina K., Dolber, Paul C., Peterson, Bercedis L., Sharma, Ketan, Mosca, Paul J., Royal, Richard, Ross, Merrick, Zager, Jonathan S., Tyler, Douglas S.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2014
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4464816/
https://ncbi.nlm.nih.gov/pubmed/25145500
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1245/s10434-014-3887-z
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi